NCT01987947View on ClinicalTrials.gov

A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria

PHASE2CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Urticaria

Interventions

DRUG

Placebo

Two administrations by subcutaneous injection

DRUG

Quilizumab

Two administrations by subcutaneous injection

Trial Locations (3)

10117

Berlin

55131

Mainz

M4V 1R2

Toronto

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY